Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Neptune strengthens balance sheet

This article was originally published in The Tan Sheet

Executive Summary

Laval, Quebec, Canada-based Neptune Technologies & Bioresources announces Nov. 24 it has conducted a private placement of common shares to raise $4.5 mil. and accelerate its development for Neptune Krill Oil. Neptune President and CEO Henri Harland says the offering enhances the company's balance sheet, which strengthens the firms negotiations regarding the product. "The derivatives from Neptune Krill Oil as a functional health ingredient for cognitive and joint health in the health food market and for the management of cardiovascular disease as a prescription drug have attracted great interest from corporations," he says...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100009

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel